Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that CorMedix Inc. made materially false and/or misleading statements and/or failed to disclose that: Cormedix reported fourth quarter and full year 2024 financial results. During the Company’s earnings call held the same day, Cormedix noted that “we do expect to begin to see some net price erosion beginning in the second quarter of 2025.” Following this news, the price of the Company’s stock dropped on March 25, 2025.
In order to be eligible to join the CRMD class action lawsuit, you must have incurred a loss on shares of CorMedix Inc. purchased during the class period listed above.
TOP
